ELAN · Elanco Animal Health Inc · Executive Compensation
$22.52
-0.17 (-0.75%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$11.25B
Shares
499.62M
Volume · Oct 23
4.28M
Avg daily vol (3M)
6.21M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Jeffrey Simmons | President and CEO | $14,925,756 |
| Todd Young | Former Executive Vice President and Chief Financial Officer | $4,754,889 |
| Robert VanHimbergen | Executive Vice President and Chief Financial Officer | $4,661,304 |
| Ellen de Brabander | Executive Vice President, Innovation and Regulatory | $3,911,229 |
| Ramiro M. Cabral | Executive Vice President, President International | $3,243,767 |
| Timothy Bettington | Executive Vice President, Center for Strategic Growth | $2,583,505 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jeffrey Simmons | President and CEO | $14,833,704 |
| Todd Young | Executive Vice President and Chief Financial Officer | $4,109,361 |
| Ellen de Brabander | Executive Vice President, Innovation and Regulatory | $3,913,932 |
| Ramiro M. Cabral | Executive Vice President, President International | $2,942,471 |
| Timothy Bettington | Executive Vice President, Global Strategy and Market Development | $2,533,389 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Jeffrey Simmons | President and CEO | $13,663,169 |
| Todd Young | Executive Vice President and Chief Financial Officer | $3,726,720 |
| Ellen de Brabander | Executive Vice President, Innovation and Regulatory | $3,683,732 |
| Ramiro M. Cabral | Executive Vice President, President International | $2,650,754 |
| Timothy Bettington | Executive Vice President, Global Strategy and Market Development | $2,053,962 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jeffrey Simmons | President and CEO | $12,713,632 |
| Todd Young | Executive Vice President and Chief Financial Officer | $3,654,484 |
| Ellen de Brabander | Executive Vice President, Innovation and Regulatory | $2,810,043 |
| Ramiro M. Cabral | Executive Vice President, President International | $2,442,850 |
| Bobby Modi | Executive Vice President, U.S. Pet Health and Global Digital Transformation | $2,222,421 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jeffrey Simmons | President and CEO | $12,060,015 |
| Aaron L. Schacht | Former Executive Vice President, Innovation, Regulatory and Business Development | $4,117,970 |
| Todd Young | Executive Vice President and Chief Financial Officer | $3,291,910 |
| Joyce Lee | Former Executive Vice President, U.S. Pet Health and Commercial Operations | $3,179,852 |
| Ramiro M. Cabral | Executive Vice President, President International | $2,220,146 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Jeffrey Simmons | President and CEO | $8,958,820 |
| Todd Young | Executive Vice President and Chief Financial Officer | $2,583,940 |
| Aaron L. Schacht | Former Executive Vice President, Innovation, Regulatory and Business Development | $2,328,369 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Jeffrey Simmons | President and Chief Executive Officer | $15,801,769 |
| Aaron L. Schacht | Former Executive Vice President, Innovation, Regulatory and Business Development | $2,826,309 |
| Todd Young | Executive Vice President and Chief Financial Officer | $2,274,132 |
| David S. Kinard | Executive Vice President, Human Resources | $1,347,589 |
| David A. Urbanek | Executive Vice President, Manufacturing and Quality | $1,193,480 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Robert (Bob) VanHimbergen | Executive Vice President and Chief Financial Officer | Appointed | 2025-05-28 |
| Stacey Ma, PhD | Board of Directors | Appointed | 2024-11-12 |
| Lawrence Kurzius | member of the Board | Appointed | 2024-06-04 |
| Kathy Turner | member of the Board | Appointed | 2024-06-04 |
| Craig Wallace | independent director | Appointed | 2024-04-01 |
| Kathy Turner | independent director | Appointed | 2024-04-01 |
| Craig S. Wallace | director of the Corporation | Appointed | 2024-04-01 |
| Kathy V. Turner | director of the Corporation | Appointed | 2024-04-01 |
| Kirk P. McDonald | Director | Appointed | 2023-05-22 |
| Deborah T. Kochevar | Director | Appointed | 2023-05-22 |
| R. David Hoover | Director | Appointed | 2023-05-22 |
| Michael J. Harrington | Director | Appointed | 2023-05-22 |
| Scott D. Ferguson | member of the Board of Directors | Resigned | 2022-09-08 |
Leadership
- Jeffrey N. Simmons CEO, Board Member
- Jeffrey Simmons CEO, Board Member
- Robert (Bob) VanHimbergen CFO
- Todd S. Young CFO
- James M. Meer Chief Accounting Officer
- Art A. Garcia Board Member
- Art Garcia Board Member
- Craig S. Wallace Board Member
- Deborah T. Kochevar Board Member
- Denise Scots-Knight Board Member
- John P. Bilbrey Board Member
- Kapila Anand Board Member
- Kapila Kapur Anand Board Member
- Kathy V. Turner Board Member
- Kirk McDonald Board Member
- Kirk P. McDonald Board Member
- Lawrence E. Kurzius Board Member
- Lawrence Kurzius Board Member
- Michael Harrington Board Member
- Michael J. Harrington Board Member
- Paul Herendeen Board Member
- Scott Ferguson Board Member
- Stacey Ma Board Member
- Stacey Ma, PhD Board Member
- William F. Doyle Board Member
Key facts
CIK
1739104
CUSIP
28414H103
13F (30d)
105 filings
101 filers
Visit website
Investor relations